1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsBARDA DRIVe I-CREATE Diagnostics and Medical Device Accelerator for Health Security is sponsored by Biomedical Advanced Research and Development Authority (BARDA) DRIVe. This opportunity supports mission-aligned projects and measurable outcomes.
Get alerted about grants like this
Save a search for “Biomedical Advanced Research and Development Authority (BARDA) DRIVe” or related topics and get emailed when new opportunities appear.
Search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
DRIVe | BARDA Accelerator Network (BAN) Fostering the growth of the global health security innovation ecosystem The five hubs create a network designed to foster the growth of the startup ecosystem by accelerating the development and commercialization of next-generation health security solutions.
Each hub sources innovative early-stage ideas in their respective technology areas, and provides funding to assess the feasibility of technology concepts and commercialization resources to accelerate product development and validation.
The BARDA Accelerator Network Hubs Select a Hub to learn more: Diagnostics / Medical Devices Consortium led by University Lab Partners, in partnership with CIMIT and Science Exchange The International Consortium for Research, Engineering, Acceleration of Technology Excellence (I-CREATE) Hub supports the development and acceleration of novel diagnostics and medical devices to detect, prevent, or respond to medical consequences that result from health security threats.
The Paratus Digital Health Hub supports the development and application of digital health tools to empower people to prepare for and respond to health security threats and improve the continuum of clinical care.
Led by MedTech Innovator (BioTools Innovator) The BioTools Innovator: VANGUARD Hub supports the development of innovations in drug discovery and development, biomanufacturing innovations to increase speed, capacity, portability, and scalability, and innovations to improve clinical research and clinical care coordination.
Consortium led by Children's National Hospital, in partnership with CIMIT, University Hospitals Rainbow Babies & Children's, and BioHealth Innovation The Special Populations Acceleration, Research and Knowledge (SPARK), Innovations in Pediatrics Hub supports the development of innovations that address challenges around the development and availability of medical countermeasures for pediatric populations.
Consortium led by Start2 Group, in partnership with Advise Connect Inspire (ACI) and BioInnovation Labs' (BioLabs) The Vaccine Innovations and Therapeutics Acceleration Launchpad (VITAL) Hub supports the development and acceleration of next-generation therapeutic and vaccine platforms and technologies.
The Network supports health security innovators, startups, and BARDA portfolio companies by providing wraparound accelerator services, including entrepreneurship education and access to technical and business/commercialization expertise and resources.
Development, Evaluation, and Validation Services The Network provides funding to startups to evaluate and validate novel medical countermeasures that align with BARDA's strategic priorities. Development, Evaluation, and Validation Services The Network provides funding to startups to evaluate and validate novel medical countermeasures that align with BARDA's strategic priorities.
Rapid Response Capability In the event of a public health emergency, the Network can rapidly fund and accelerate product development and validation of medical countermeasures that can be developed and deployed as quickly as possible. Learn more about the previous generation of the BARDA Accelerator Network and its partners that continue to support the acceleration of novel life sciences innovations.
If you are interested in working with us, please contact us below: This link goes to a non-USG site. This site may not have USG standard privacy control. Click OK to proceed in a separate browser window.
According to the current listing, eligibility includes: Startups, small businesses, and university-backed projects worldwide developing innovative diagnostic or medical device technologies addressing health security threats. Confirm the full requirements in the official notice before applying.
The current listing shows non-dilutive funding of $50,000 to $200,000 per team. Additional showcase prize awards of up to $50,000. Verify award ceilings, matching requirements, and allowable costs in the official notice.
BARDA DRIVe I-CREATE Diagnostics and Medical Device Accelerator for Health Security is funded by Biomedical Advanced Research and Development Authority (BARDA) DRIVe. Verify program details on the funder's official page before applying.
Yes — this listing is flagged as national in scope, so applicants across the U.S. may apply, subject to the sponsor's other eligibility criteria.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
The April 14 SBIR/STTR reauthorization restarted NIH's small-business pipeline after the shutdown, but the real signal is the sequencing of the new Small Business 101 webinars: program overview June 9, budget July 14, foreign risk August 18.
Read articleNIH's accelerating use of multiyear-funded grants — 601 awards worth $402 million in the first half of FY26, against just 146 awards worth $75 million in the same window of FY24 — has produced a fiscal contraction at research universities that has begun cascading into PhD admissions. AAU member institutions are admitting smaller graduate cohorts than they did in 2024 or 2025, with downstream consequences for the biomedical workforce, lab continuity, and the foreign-student pipeline through 2030. Why the contraction is structural rather than cyclical, and what universities, PIs, and prospective trainees should be doing in the second half of 2026.
Read articleARPA-H launched the Intelligent Generator of Research program on May 5, 2026 with only three anticipated OT awards, a Solution Summary deadline of June 25, and a full proposal due August 6. The program is also piloting LLM-assisted proposal review. Here is the strategic read.
Read article